Knockdown of SMAD3 enhanced the cytotoxicity of NK92 cells against human hepatoma or melanoma cells as well as the production of IFN-γ via E4BP4, even in the presence of high amounts of TGF-β [102]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.